Pharmafile Logo
Pharmafocus logo
Advanced Search

Smurfit Westrock unveils new clinical packaging facility at Dublin Airport

November 13, 2025
Medical Communications Dublin, Smurfit Westrock, clinical packaging facility

Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. …

News

EVerZom enters research and licensing agreement with GENFIT

November 13, 2025
Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement

EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …

News
drug-trials

University of Birmingham scientists develop new MRI contrast agent

November 12, 2025
Research and Development Diagnostics, MRI, University of Birmingham, medical imaging

Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …

News

Custom Pharmaceuticals launches new company for drug product development

November 12, 2025
Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex

Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …

News

Novartis receives SMC approval for early breast cancer treatment

November 11, 2025
Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland

Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …

News

Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers

November 10, 2025
Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases

Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …

News

Richmond Pharmacology appoints Dr Edward Jackson as Medical Director

November 7, 2025
CRO, Richmond Pharmacology, biotech, clinical trials

Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …

Appointment

Vesper Bio reports positive topline results for dementia candidate

November 7, 2025
Research and Development Frontotemporal degeneration, Vesper Bio, clinical trials, dementia

Vesper Bio, a clinical-stage biotech developing novel oral therapies for neurodegenerative and neuropsychiatric disorders, has reported positive topline data from …

News

AAX Biotech and ToxoTech partner to develop next-gen biotherapeutics for neurological disorders

November 7, 2025
Research and Development AAX Biotech, Biotherapeutics, ToxoTech, neurological disorders

AAX Biotech, a biotech company specialising in next-generation antibody therapeutics, has entered a strategic partnership with ToxoTech, a biopharma company …

News

Ardena appoints new Chief Quality Officer and Chief Information Officer

November 6, 2025
Ardena, CDMO, CRO, Chief Information Officer, chief quality officer

Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, …

Appointment

Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO

November 5, 2025
Draig Therapeutics, Neuropsychiatry, neuroscience

Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …

Appointment

Von Willebrand disease – increasing awareness and access to vital care

November 4, 2025
Medical Communications, Research and Development European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …

Feature

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025
Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Feature

VALANX Biotech appoints Klaus Orlinger as Chief Scientific Officer

November 4, 2025
Antibody-Drug Conjugate, VALANX Biotech, drug development

VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …

Appointment

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

November 3, 2025
Medical Communications, Research and Development Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

Feature

Five Facts about men’s mental health

October 31, 2025
Medical Communications Five Facts, mental health, men’s mental health

1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …

Feature

AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics

October 31, 2025
AAX Biotech, Daiichi Sankyo, Opti-mAb, Seqitope

AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …

News
partnership

Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies

October 30, 2025
Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership

Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …

News

Is this an Oppenheimer moment for the life sciences industry?

October 29, 2025
Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Feature
Thought Leadership
drug-trials

Pharma&’s ovarian cancer therapy approved for use by NHS Scotland

October 29, 2025
Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026